Adoption of highly effective contraception and prevention of unintended pregnancy in adolescent girls by providing the etonogestrel-releasing implant (Implanon NXT®) in the immediate postpartum period (IPP), compared with any choice of method 6 weeks PP (standard of care (SOC))
Financing : Schering-Plough Industria Farmacêutica Ltda.
Researcher : Dr. Luis Bahamondes
Line of Research : Contraception